Cost Plus Drugs

MasterClass Announces Mark Cuban's Class on Winning Big in Business

Retrieved on: 
Jeudi, février 22, 2024
Cost Plus Drugs, Thought, Television, Shark Tank, MasterClass, ABC, Dallas Mavericks, NBA

SAN FRANCISCO, Feb. 22, 2024 /PRNewswire/ -- MasterClass, the streaming platform where anyone can learn from the world's best, today announced that billionaire investor and disruptive entrepreneur Mark Cuban will teach a class on how to win big in business. Members will get insights from Cuban that aren't taught in traditional business school curriculums, including how to find million-dollar opportunities, grow businesses and cash out big. The class is available now exclusively on MasterClass, where subscribers have unlimited access to all 200+ instructors with an annual membership.

Key Points: 
  • Members will get insights from Cuban that aren't taught in traditional business school curriculums, including how to find million-dollar opportunities, grow businesses and cash out big.
  • The class is available now exclusively on MasterClass , where subscribers have unlimited access to all 200+ instructors with an annual membership.
  • In this class, Cuban will detail his thought process and deliberation in business, focusing on how MasterClass members can spot opportunities for disruption where others do not.
  • "I partnered with MasterClass because I want members to meet and exceed every goal in business they've ever had.

Liviniti and Mark Cuban Cost Plus Drug Company Team Up for More Affordable Prescription Drugs

Retrieved on: 
Jeudi, janvier 25, 2024
Cost Plus Drugs, PBM, Partnership, Pharmacy, Patient, Health, Pharmaceutical industry

Industry-leading PBM, Liviniti, adds Mark Cuban Cost Plus Drug Company to its network of pharmacy options for members

Key Points: 
  • Natchitoches, Louisiana--(Newsfile Corp. - January 25, 2024) - Long recognized as a PBM leader in transparency and prescription drug savings, Liviniti is excited to announce the addition of the Mark Cuban Cost Plus Drug Company ( Cost Plus Drugs ) to its network of pharmacies.
  • "Our Cost Plus Drugs collaboration opens a new avenue to increased savings for members," said LeAnn Boyd, Liviniti CEO.
  • "We are excited to join forces with a like-minded company such as Liviniti," said Alex Oshmyansky, CEO of Mark Cuban Cost Plus Drug Company.
  • "At Cost Plus Drugs, we are committed to revolutionizing the pharmaceutical landscape through transparent drug pricing and working with Liviniti aligns seamlessly with our mission.

SmithRx Continues to Fix Broken Pharmacy Benefits Management System, Closes $60M in Series C Funding Led by Venrock

Retrieved on: 
Mardi, janvier 23, 2024
Professional Services, Managed Care, Other Consumer, Health, Women, Pharmaceutical, Men, Insurance, Consumer, Human Resources, Finance, Cost Plus Drugs, Silicon, PBM, Pharmacy, Venrock, Patient, Insulin, Amazon Pharmacy, Pharmaceutical industry

SmithRx , a next-generation pharmacy benefits management (PBM) company, closed a $60M Series C financing round — building on the company’s $20M Series B round raised in 2022.

Key Points: 
  • SmithRx , a next-generation pharmacy benefits management (PBM) company, closed a $60M Series C financing round — building on the company’s $20M Series B round raised in 2022.
  • Led by top Silicon Valley healthcare venture capital firm Venrock , the latest funding positions SmithRx to continue reducing costs of pharmacy benefits for small and midsize self-insured businesses.
  • “Medications in the U.S. cost too much because the overall system is broken,” said Jake Frenz , founder and CEO of SmithRx.
  • “At the core of this broken system are pharmacy benefit managers that drive up the costs.

Mark Cuban Cost Plus Drug Company and Sidecar Health team up to tackle rising healthcare costs

Retrieved on: 
Mardi, janvier 9, 2024
Insurance, Specialty, Professional Services, Health Insurance, Health, Pharmaceutical, General Health, Retail, Online Retail, Sidecar Health, Leukemia, PBC, Cost Plus Drugs, Prescription, Pharmacy, Imatinib, Tablet, World Market (store), Gallup, Pharmaceutical industry

Sidecar Health, a transformative health insurance company giving its members control over costs and choice, announced today that it is teaming up with Mark Cuban Cost Plus Drug Company, PBC (Cost Plus Drugs) to help bring high-quality, lower-cost prescription drugs to Sidecar Health members.

Key Points: 
  • Sidecar Health, a transformative health insurance company giving its members control over costs and choice, announced today that it is teaming up with Mark Cuban Cost Plus Drug Company, PBC (Cost Plus Drugs) to help bring high-quality, lower-cost prescription drugs to Sidecar Health members.
  • Both Sidecar Health and Cost Plus Drugs were founded to address the issue of rising healthcare costs, which are often driven by lack of transparency and inefficient middlemen that inflate the overall cost of healthcare services.
  • Together, Sidecar Health and Cost Plus Drugs are fostering a healthcare landscape that is transparent, consumer-friendly, and genuinely cost-effective.
  • “Cost Plus Drugs and Sidecar Health are working together to change that.” By eliminating administrative complexities and offering transparency, Sidecar Health and Cost Plus Drugs are making prescription drugs more affordable and taking a significant step toward accessible healthcare for all.

Meet the Stars: Celebrity Guests at CES 2024

Retrieved on: 
Jeudi, décembre 28, 2023
Cost Plus Drugs, Dallas Mavericks, NPR, TED Radio Hour, Radio, Shark Tank, Medialink, Consumer Technology Association, NBA, AARP, Swagger, Netflix, Advertising, CES, CTA

ARLINGTON, Va., Dec. 28, 2023 /PRNewswire/ -- The Consumer Technology Association (CTA)® today announced a star-studded lineup of celebrity appearances coming to CES 2024®, January 9-12 in Las Vegas.

Key Points: 
  • ARLINGTON, Va., Dec. 28, 2023 /PRNewswire/ -- The Consumer Technology Association (CTA)® today announced a star-studded lineup of celebrity appearances coming to CES 2024®, January 9-12 in Las Vegas.
  • CES welcomes celebrities and ambassadors for the world's best-known brands, and this year is no exception.
  • "CES has a long history of welcoming celebrities and ambassadors for the world's most well-known brands, and this year is no exception," said Gary Shapiro, president and CEO, CTA.
  • Stay tuned and follow CES social media channels for more celebrity announcements.

Celiac Disease Foundation Teams Up with Mark Cuban Cost Plus Drug Company

Retrieved on: 
Mercredi, décembre 6, 2023
Retail, Health, Other Retail, Fitness & Nutrition, General Health, Pharmaceutical, Policy, Cost Plus Drugs, Food, Pharmacist, Risk, Mortality, Cardiovascular disease, Patient, Multimedia, Respiratory disease, Private sector, World Market (store), Social media, Cancer, Diagnosis, Coeliac disease, Lymphoma, Dentistry

The Celiac Disease Foundation , a global leader in celiac disease patient advocacy, today announces its new relationship with Mark Cuban Cost Plus Drug Company ( Cost Plus Drugs ) to provide resources for celiac disease patients and all consumers concerned about potential gluten in the company’s medications.

Key Points: 
  • The Celiac Disease Foundation , a global leader in celiac disease patient advocacy, today announces its new relationship with Mark Cuban Cost Plus Drug Company ( Cost Plus Drugs ) to provide resources for celiac disease patients and all consumers concerned about potential gluten in the company’s medications.
  • We are pleased and proud to join forces with Mark Cuban Cost Plus Drug Company to provide peace of mind to our celiac disease community.”
    Cost Plus Drugs’ pharmacy fulfillment partners can address inquiries regarding gluten content in medications, ensuring that those with celiac disease can confidently navigate their needs with the guidance of knowledgeable pharmacists.
  • “We are thrilled to be working with the Celiac Disease Foundation,” said Dr. Alex Oshmyansky, CEO of Mark Cuban Cost Plus Drug Company.
  • Living with celiac disease is a daily struggle, and it also increases the mortality risks for cancer, cardiovascular disease, and respiratory disease.

Mark Cuban Cost Plus Drug Company Teams Up With PBM PCA Rx

Retrieved on: 
Lundi, décembre 18, 2023
PBC, Workforce, Doctor of Pharmacy, World Market (store), Rx, Cost Plus Drugs, PCA, Health, SAN, PBM, Pharmaceutical industry

SAN ANTONIO, Dec. 18, 2023 /PRNewswire-PRWeb/ -- [PCA Rx], a leading provider of pharmacy benefit management (PBM) services, is proud to announce a relationship with Mark Cuban Cost Plus Drug Company, PBC [Cost Plus Drugs], a trailblazer in drug pricing disruption. This collaboration aims to bring transparency, accessibility, and affordability to drug pricing for employers and individuals nationwide in an industry long plagued by hidden costs and lack of transparency.

Key Points: 
  • PCA Rx, a leading provider of pharmacy benefit management (PBM) services, is proud to announce a relationship with Mark Cuban Cost Plus Drug Company, a trailblazer in drug pricing disruption.
  • SAN ANTONIO, Dec. 18, 2023 /PRNewswire-PRWeb/ -- [ PCA Rx ], a leading provider of pharmacy benefit management (PBM) services, is proud to announce a relationship with Mark Cuban Cost Plus Drug Company, PBC [ Cost Plus Drugs ], a trailblazer in drug pricing disruption.
  • "We are excited to join forces with a like-minded company such as PCA Rx", said Alex Oshmyansky, CEO of Mark Cuban Cost Plus Drug Company.
  • "We are excited to join forces with a like-minded company such as PCA Rx", said Alex Oshmyansky, CEO of Mark Cuban Cost Plus Drug Company.

This Week in Health News: 10 Stories You Need to See

Retrieved on: 
Vendredi, décembre 1, 2023
X-ray, CTS, Transesophageal echocardiogram, Health equity, Bristol Myers Squibb, Research, Magnetic resonance imaging, Bank, Nicklaus Children's Hospital, Kohl's, Cardiology, Cost Plus Drugs, Award, Avidity, Database, CAA, Related, Vaccine, Hostess, Infection, Rehabilitation, NFID, NAMI, Grace, Pharmacy, Burns, MPH, Geography, Subject-matter expert, Survivor, Mental health, PR Newswire, Creative Artists Agency, Bank of America, News, Environment, Nextgen, Nursing, Pharmaceutical industry, Publishing, Adobe, MD, Boeing

NEW YORK, Dec. 1, 2023 /PRNewswire/ -- With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help journalists covering the healthcare industry stay on top of the week's most newsworthy and popular releases, here's a roundup of stories from the week that shouldn't be missed.

Key Points: 
  • Together, we're reshaping the narrative around drug costs, setting a new industry standard."
  • "We are excited to expand our collaboration with Bristol Myers Squibb, who are world leaders in cardiovascular drug discovery and development.
  • Subject Matter Experts: Access ProfNet , a database of industry experts to connect with as sources or for quotes in your articles.
  • Related Resources: Read and subscribe to our journalist- and blogger-focused blog, Beyond Bylines , for media news roundups, writing tips, upcoming events, and more.

Expion Health and Mark Cuban Cost Plus Drug Company, PBC Forge Innovative Collaboration to Enhance Pharmacy Cost Management

Retrieved on: 
Lundi, novembre 27, 2023
PBC, Cost Plus Drugs, Pharmacy, Environment, Health, Optimism, Pharmaceutical industry

GAITHERSBURG, Md., Nov. 27, 2023 /PRNewswire/ -- Today, Expion Health, a pioneer in leveraging powerful technology and dynamic pricing strategies, unveiled its new collaboration with Mark Cuban Cost Plus Drug Company, PBC (Cost Plus Drugs). This strategic alliance will integrate Cost Plus Drugs' revolutionary pricing into Expion Health's product suite, offering an innovative way to tackle the escalating costs of specialty drugs.

Key Points: 
  • GAITHERSBURG, Md., Nov. 27, 2023 /PRNewswire/ -- Today, Expion Health, a pioneer in leveraging powerful technology and dynamic pricing strategies, unveiled its new collaboration with Mark Cuban Cost Plus Drug Company, PBC (Cost Plus Drugs).
  • Karin Humphrey, Chief Executive Officer of Expion Health, spoke on this new venture: "By teaming up with Cost Plus Drugs, we're amplifying our sourcing capabilities and deepening transparency in pharmacy cost management.
  • "We are excited to work with Expion Health to bring lower prescription drug prices to consumers," said Alex Oshmyansky, CEO of Mark Cuban Cost Plus Drug Company.
  • This collaboration symbolizes a shared vision for the future of pharmacy cost management, fostering optimism for more accessible medication solutions.

PharmcoRx Pharmacy Launches Mark Cuban Cost Plus Drug Program Expanding Its In-Pharmacy Offerings

Retrieved on: 
Lundi, novembre 27, 2023
Acquisition, OTCQB, MCCPDC, Organization, Patient, Pharmacy, Prescription, Cost Plus Drugs, Health, Pharmaceutical industry

MIAMI, Nov. 27, 2023 /PRNewswire/ -- PharmcoRx Pharmacy, a wholly-owned subsidiary of Progressive Care Inc (OTCQB:RXMD), today announced its expansion of in-pharmacy offerings through an agreement with the Mark Cuban Cost Plus Drug Company ("Cost Plus Drugs").

Key Points: 
  • MIAMI, Nov. 27, 2023 /PRNewswire/ -- PharmcoRx Pharmacy, a wholly-owned subsidiary of Progressive Care Inc (OTCQB:RXMD), today announced its expansion of in-pharmacy offerings through an agreement with the Mark Cuban Cost Plus Drug Company ("Cost Plus Drugs").
  • The Cost Plus Drugs program allows participating patients the ability to purchase generic and branded medicines at their cost plus a low fixed markup.
  • The Mark Cuban Cost Plus Drug Company ("MCCPDC") offers more than 1,000 drugs at their actual acquisition cost plus a transparent 15% markup.
  • By partnering with organizations such as the Mark Cuban Cost Plus Drug Company and our ongoing initiatives to expand our pharmacy service offerings and reach, we are continuing our mission to make positive contributions to the health of our customers."